Department of Otolaryngology, New Cross Hospital, The Royal Wolverhampton NHS Trust, Wolverhampton, UK.
Department of Otolaryngology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Br J Neurosurg. 2024 Apr;38(2):498-502. doi: 10.1080/02688697.2021.1905771. Epub 2021 Mar 26.
The incidence of CSF leak following endoscopic transsphenoidal surgery remains the most important measure in the success of any repair. The nasoseptal flap (NSF) has played a pivotal role in reconstructing defects. However, morbidity associated with the NSF includes bleeding, septal injury, altered smell and crusting. Tachosil is an absorbable fibrin sealant patch that promotes haemostasis and wound healing. The purpose of this study was to evaluate the effectiveness of Tachosil to repair intraoperative defects during an endoscopic transsphenoidal approach.
All patients who underwent an endoscopic transsphenoidal approach with the use of Tachosil at the Queen Elizabeth Hospital Birmingham, between January 2013 and June 2020 were retrospectively analysed. Tachosil was used as an overlay patch over of the bony defect, in a multi-layered repair depending on the defect and grade of CSF leak. The primary outcome measure was post-operative CSF leak.
A total of 52 primary procedures where Tachosil was used as the overlay were analysed. There were 23 (44.2%) intraoperative CSF leaks. The overall post-operative CSF leak rate was 7.8% ( = 4), with all cases having had a Tachosil overlay reconstruction with no NSF. A formal NSF was harvested in only five cases alongside the Tachosil patch, where a grade 2 or more leak was identified at the time of the primary procedure, none of which developed a post-operative leak. No patient had any post-operative adverse outcomes that were attributed to Tachosil.
We believe this to be the largest case series evaluating the endoscopic use of Tachosil in skull base reconstruction. Our data show that in endoscopic transsphenoidal approach, Tachosil may be used safely in a multi-layered approach as an effective alternative to the NSF in low flow CSF leak cases, or alongside a NSF in higher flow leaks.
内镜经蝶窦手术后脑脊液漏的发生率仍然是任何修复成功的最重要指标。鼻中隔瓣(NSF)在重建缺陷方面发挥了关键作用。然而,与 NSF 相关的发病率包括出血、鼻中隔损伤、嗅觉改变和结痂。Tachosil 是一种可吸收的纤维蛋白密封剂贴片,可促进止血和伤口愈合。本研究旨在评估 Tachosil 在经蝶窦内镜手术中修复术中缺陷的有效性。
回顾性分析了 2013 年 1 月至 2020 年 6 月期间在伯明翰伊丽莎白女王医院接受经蝶窦内镜手术并使用 Tachosil 的所有患者。Tachosil 用作骨缺损的覆盖贴片,根据缺损和 CSF 漏的程度进行多层修复。主要观察指标是术后 CSF 漏。
共分析了 52 例使用 Tachosil 作为覆盖物的原发性手术。术中 CSF 漏 23 例(44.2%)。总的术后 CSF 漏发生率为 7.8%( = 4),所有病例均采用 Tachosil 覆盖重建,未使用 NSF。仅在 5 例病例中采集了正式的 NSF,同时在原发性手术中发现了 2 级或更高等级的漏,这些病例均未发生术后漏。没有患者因 Tachosil 出现任何术后不良后果。
我们认为这是评估 Tachosil 在颅底重建中内镜应用的最大病例系列。我们的数据表明,在经蝶窦内镜手术中,Tachosil 可安全地用于多层方法,作为低流量 CSF 漏病例中 NSF 的有效替代方法,或与高流量漏时的 NSF 一起使用。